Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × Glioma × Cilengitide × Clear all

Phase

Status

Terminated 1 Completed 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Glioblastoma 5 Oligodendroglioma 3 Lymphoma, Follicular 3 Gliosarcoma 3 Brain Neoplasms 3 Astrocytoma 3 Prostatic Neoplasms 2 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 2 Precursor Cell Lymphoblastic Leukemia-Lymphoma 2 Optic Nerve Glioma 2 Lymphoma, T-Cell, Cutaneous 2 Lymphoma, Non-Hodgkin 2 Lymphoma, Mantle-Cell 2 Lymphoma, Large-Cell, Immunoblastic 2 Lymphoma, Large B-Cell, Diffuse 2 Lymphoma, B-Cell, Marginal Zone 2 Leukemia, Lymphocytic, Chronic, B-Cell 2 Immunoblastic Lymphadenopathy 2 Hodgkin Disease 2 Carcinoma, Non-Small-Cell Lung 2 Burkitt Lymphoma 2 Waldenstrom Macroglobulinemia 1 Unspecified Adult Solid Tumor, Protocol Specific 1 Triple Negative Breast Neoplasms 1 Thrombocythemia, Essential 1 Sezary Syndrome 1 Renal Insufficiency 1 Recurrence 1 Primary Myelofibrosis 1 Precancerous Conditions 1

Interventions

Temozolomide 74 Bevacizumab 44 Radiotherapy 30 Irinotecan 17 Magnetic Resonance Spectroscopy 16 Carboplatin 16 Surgical Procedures, Operative 13 Carmustine 13 Radiation 9 Nivolumab 8 Lomustine 7 Imatinib Mesylate 7 IL13-PE38 7 Everolimus 7 Topotecan 6 Thalidomide 6 Radiotherapy, Intensity-Modulated 6 Erlotinib Hydrochloride 6 Chemotherapy, Adjuvant 6 Aminolevulinic Acid 6 sargramostim 5 fluorodopa F 18 5 Vincristine 5 Surveys and Questionnaires 5 Radiosurgery 5 Filgrastim 5 Blood Specimen Collection 5 vandetanib 4 temsirolimus 4 ribociclib 4

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01165333 2026-03-16

CILENT

Centre Oscar Lambret

Phase 1 Completed

Diffuse Intrinsic Pontine Glioma, Glioma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡